MENU
+Compare
FMS
Stock ticker: NYSE
AS OF
Sep 4, 10:46 AM (EDT)
Price
$24.38
Change
+$0.02 (+0.08%)
Capitalization
14.3B

FMS Fresenius Medical Care AG Forecast, Technical & Fundamental Analysis

Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024... Show more

FMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for FMS with price predictions
Sep 03, 2025

FMS in +1.63% Uptrend, growing for three consecutive days on August 22, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where FMS advanced for three days, in of 312 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where FMS's RSI Oscillator exited the oversold zone, of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for FMS just turned positive on August 14, 2025. Looking at past instances where FMS's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

FMS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 57 cases where FMS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on September 02, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on FMS as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FMS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for FMS entered a downward trend on August 14, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.925) is normal, around the industry mean (8.719). P/E Ratio (18.649) is within average values for comparable stocks, (116.752). Projected Growth (PEG Ratio) (0.375) is also within normal values, averaging (1.984). Dividend Yield (0.032) settles around the average of (0.039) among similar stocks. P/S Ratio (0.625) is also within normal values, averaging (1.647).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. FMS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FMS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.

View a ticker or compare two or three
FMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

FMS is expected to report earnings to fall 37.63% to 56 cents per share on November 04

Fresenius Medical Care AG FMS Stock Earnings Reports
Q3'25
Est.
$0.57
Q2'25
Beat
by $0.41
Q1'25
Beat
by $0.07
Q4'24
Missed
by $0.26
Q3'24
Beat
by $0.35
The last earnings report on August 05 showed earnings per share of 91 cents, beating the estimate of 50 cents. With 687.00 shares outstanding, the current market capitalization sits at 14.30B.
A.I.Advisor
published Dividends

FMS paid dividends on June 06, 2025

Fresenius Medical Care AG FMS Stock Dividends
А dividend of $0.79 per share was paid with a record date of June 06, 2025, and an ex-dividend date of May 23, 2025. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of renal and dialysis products

Industry HospitalNursingManagement

Profile
Fundamentals
Details
Industry
Medical Or Nursing Services
Address
Else-Kroener-Strasse 1
Phone
+49 791033353
Employees
119845
Web
https://www.freseniusmedicalcare.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
APUE39.370.17
+0.43%
ActivePassive U.S. Equity ETF
REK17.030.04
+0.25%
ProShares Short Real Estate
ZJAN26.690.04
+0.17%
Innovator Equity Defined Protection ETF - 1 Yr January
AGZD22.290.02
+0.09%
WisdomTree Interest RtHdgUS Aggt Bd ETF
BRW8.25-0.08
-0.96%
Saba Capital Income & Opportunities Fund

FMS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, FMS has been loosely correlated with DVA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if FMS jumps, then DVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FMS
1D Price
Change %
FMS100%
N/A
DVA - FMS
42%
Loosely correlated
-0.72%
OPCH - FMS
32%
Poorly correlated
+1.72%
CHE - FMS
26%
Poorly correlated
-0.94%
JYNT - FMS
24%
Poorly correlated
-0.28%
USPH - FMS
23%
Poorly correlated
-0.20%
More

Groups containing FMS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FMS
1D Price
Change %
FMS100%
N/A
Hospital/Nursing Management
industry (89 stocks)
13%
Poorly correlated
+0.02%